The program attracted the participation of 250 delegates attending in person and 200 health workers participating online.
Experts have focused on discussing new treatment solutions to reduce child mortality, specifically the breakthrough immunosupportative method using single-line antibodies that will help prevent the process of permingling and inhibit RSV copulation, thereby reducing the proliferation of the virus, preventing the spread of RSV in pediatric patients.
With the above mechanism, this advanced solution provides a proactive protection mechanism, helping to effectively prevent serious respiratory diseases caused by RSV in high-risk children including premature birth, children with bronchial-nherococcal disorder and children with congenital heart disease. With 27 years of clinical experience globally, applied in more than 100 countries, the solution has now officially appeared in Vietnam, opening a new chapter full of hope in reducing the burden of disease and dangerous complications caused by RSV for Vietnamese children.
